Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients

Annals of Oncology

Volumn 24, Issue 2, 2013, Pages 463-468

  Chen, I C ^a   Hsu, C ^a   Chen, Y C ^a   Chien, S F ^a   Kao, H F ^a   Chang, S Y ^a   Hu, F C ^b   Yeh, K H ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Port a associated bloodstream infection; Risk score; Solid cancer

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER STAGING; CATHETER INFECTION; CHRONIC DRUG ADMINISTRATION; DRUG USE; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT IDENTIFICATION; PORT A ASSOCIATED BLOODSTREAM INFECTION SCORE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SOLID TUMOR; TOTAL PARENTERAL NUTRITION; VASCULAR ACCESS;

EID: 84873810896     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds468     Document Type: Article

References (32)

1. Vescia S, Baumgartner AK, Jacobs VR et al. Management of venous port systems in oncology: a review of current evidence. Ann Oncol 2008; 19: 9-15.
2. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007; 7: 645-657.
3. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
4. Maki DG, Kluger DM, Crnich C. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81: 1159-1171.
5. Biffi R, Corrado F, de Braud F et al. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Eur J Cancer 1997; 33: 1190-1194.
6. Huang WT, Chen TY, Su WC et al. Implantable venous port-related infections in cancer patients. Support Care Cancer 2004; 12: 197-201.
7. Liaw CC, Chen JS, Chang HK et al. Symptoms and signs of port-related infections in oncology patients related to the offending pathogens. Int J Clin Pract 2008; 62: 1193-1198.
8. Chang L, Tsai JS, Huang SJ et al. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control 2003; 31: 34-39.
9. Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin 2008; 58: 323-346.
10. Mollee P, Jones M, Stackelroth J et al Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study. J Hosp Infect 2011; 78: 26-30.
11. Chen WT, Liu TM, Wu SH et al. Improving diagnosis of central venous catheterrelated bloodstream infection by using differential time to positivity as a hospitalwide approach at a cancer hospital. J Infect 2009; 59: 317-323.
12. Raad I, Hachem R, Hanna H et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 2007; 26: 549-556.
13. Chuang YC, Chen YC, Chang SC et al. Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981-2007. J Hosp Infect 2010; 76: 143-149.
14. Edge SB, Byrd DR, Compton CC et al. AJCC Cancer Staging Manual, 7th edition. New York: Springer Verlag 2010.
15. Freifeld AG, Bow EJ, Sepkowitz KA et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 2011; 52: e56-e93.
16. Shen YC, Hsu C, Chen LT et al. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. J Hepatol. 2010; 52: 889-894.
17. Apostolopoulou E, Raftopoulos V, Terzis K et al. Infection probability score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patients. BMC Infect Dis 2010; 10: 135.
18. Velasco E, Portugal RD, Salluh JI. A simple score to predict early death in adult cancer patients with bloodstream infections. J Infect 2009; 59: 332-336.
19. Rotstein C, Brock L, Roberts RS. The incidence of first Hickman catheter-related infection and predictors of catheter removal in cancer patients. Infect Control Hosp Epidemiol 1995; 16: 451-458.
20. Anatoliotaki M, Valatas V, Mantadakis E et al. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection 2004; 32: 65-71.
21. Velasco E, Byington R, Martins CA et al. Comparative study of clinical characteristics of neutropenic and non-neutropenic adult cancer patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 2006; 25: 1-7.
22. Chee L, Brown M, Sasadeusz J et al. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies. J Infect 2008; 56: 227-233.
23. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706-1715.
24. Bosco JA, III, Slover JD, Haas JP. Perioperative strategies for decreasing infection: a comprehensive evidence-based approach. J Bone Joint Surg Am 2010; 92: 232-239.
25. Kallman J, Friberg O. Antibiotic prophylaxis in cardiac surgery-general principles. APMIS 2007; 115: 1012-1015.
26. Karanlik H, Kurul S, Saip P et al. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial. Am J Surg 2011; 202: 10-15.
27. Di Carlo I, Toro A, Pulvirenti E et al. Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study. Surg Oncol 2011; 20: 20-25.
28. Chaiyakunapruk N, Veenstra DL, Lipsky BA et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136: 792-801.
29. Casey AL, Mermel LA, Nightingale P et al. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 763-776.
30. Snaterse M, Rüger W, Scholte Op Reimer WJ et al. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect 2010; 75: 1-11.
31. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006; 43: 474-484.
32. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332.